Goldman Sachs Maintains Neutral on Dentsply Sirona, Raises Price Target to $39
Goldman Sachs analyst Nathan Rich maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises the price target from $34 to $39.
Dentsply Sirona Earnings Preview
Dentsply Sirona (NASDAQ:XRAY) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here’s what investors…
Dentsply Sirona Gets Analyst Upgrade After Positive Mixture Of Preliminary Results, Update
On Wednesday, Dentsply Sirona Inc (NASDAQ:XRAY) announced interim FY22 sales above the high end of the company’s prior outlook range…
Dentsply Sirona Q3 Adj EPS $0.41 Misses $0.59 Estimate, Sales $947.00M Miss $1.03B Estimate
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.59 by 30.51 percent. This is a 31.67 percent decrease over earnings of $0.60 per share from
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Tyson Foods, AECOM And 3 Stocks To Watch Heading Into Monday
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 402 companies made new 52-week lows.
